Track Record in Numbers:
| Clinical Centres | 40 |
| Investigators | 175 |
| Countries | 6 |
| Studies | 22 |
| Clinical Phase II | 10 |
| Clinical Phase III | 9 |
| Clinical Phase IV | 3 |
| Consultancy Assignments | 17 |
| Blinded Reads | 5 |
January 2010
pharmtrace has won more than 40 assignments and achieved consistent annual increases in the number and complexity of assignments won since its founding in 2006. This is also reflected in the increasing size and diversity of our client base. Customers of pharmtrace include biotech and academia, as well as internationally acting pharmaceutical companies and device manufacturers.
pharmtrace's network of clinical and imaging centres is continuously expanding and now includes centres in 6 countries - France, Germany, Italy, Spain, Switzerland, and The Netherlands. Within our network of clinical centres we have worked closely with a wide range of departments including: Internal Medicine, Surgery, Gastroenterology, Neuroradiology, Haematology & Oncology, Diagnostic and Interventional Radiology, Nuclear Medicine.
| Medical need assessment & Due Diligence | 11 |
| Optimisation of clinical development plan | 2 |
| Regulatory support | 2 |
| Lifecycle management & scientific publication support | 2 |
| TOTAL | 17 |
| Therapeutic area | Subjects | |
| CNS | Multiple Sclerosis | 70 |
| Stroke | 112 | |
| CARDIOVASCULAR | Coronary artery disease | 97 |
| Venous thrombosis | 70 | |
| ARTHRITIS | Rheumatoid | 10 |
| Pelvic spondylarthritis | 69 | |
| CANCER | Liver | 757 |
| Breast | 78 | |
| Kidney | 50 | |
| Prostate | 300 | |
| Bone | 108 | |
| Brain | 93 | |
| Neck/ Throat | 20 | |
| Rectal | 30 | |
| TOTAL | 1864 |
| Clinical Centres | 40 |
| Investigators | 175 |
| Countries | 6 |
| Studies | 22 |
| Clinical Phase II | 10 |
| Clinical Phase III | 9 |
| Clinical Phase IV | 3 |
| Consultancy Assignments | 17 |
| Blinded Reads | 5 |
January 2010